Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development

Fig. 2

Treatment with Sulindac-PC results in significantly less gastric toxicity compared to Sulindac. a Gastric Inflammation by treatment. b Hyperplasia of the glandular epithelium by treatment. c Ulcer Prevalence by treatment. d Example images of scored lesions, arrows indicate specified lesions. Scale bar = 500 μm. No Treatment (○), PBS (□), PC (∆), Sulindac (), Sulindac-PC (◊)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us